Muromoto Ryuta

ムロモトリユウタ | Muromoto Ryuta

Affiliation and department：
Job title： Associate professor

Research field (1)： Pharmaceuticals - health and biochemistry

Research keywords (10)：サイトカイン , TYK2 , インターフェロン , 免疫 , シグナル伝達 , 核内受容体 , 自己免疫疾患 , 炎症 , 環境化学物質 , IL-17

Research theme for competitive and other funds (14)：

2023 - 2025 ポストコロナの感染症・がん予防に向けての貪食促進型赤血球ワクチンの創製
2020 - 2023 自己免疫疾患発症制御に関与するTYK2新規機能の同定
2019 - 2022 アレルギー、免疫疾患制御に向けてのシグナル調節機構の解明
2019 - 2022 Effects of microplastic-derived chemicals on functions of regulatory T cells via nuclear receptor Nr4a.
2017 - 2020 IL-17A誘導性mRNA安定化応答が免疫疾患形成に果たす役割の解明

Show all

Papers (105)：

Kota Kagohashi, Yuto Sasaki, Kiyotaka Ozawa, Takuya Tsuchiya, Shoya Kawahara, Kodai Saitoh, Michiko Ichii, Jun Toda, Yasuyo Harada, Masato Kubo, et al. Role of Signal-Transducing Adaptor Protein-1 for T Cell Activation and Pathogenesis of Autoimmune Demyelination and Airway Inflammation. The Journal of Immunology. 2024
Jun-Ichi Kashiwakura, Shoya Kawahara, Iori Inagaki, Kyosuke Inui, Kodai Saitoh, Kota Kagohashi, Yuto Sasaki, Fuki Kobayashi, Yuichi Kitai, Ryuta Muromoto, et al. STAP-2 negatively regulates BCR-mediated B cell activation by recruiting tyrosine-protein kinase CSK to LYN. FEBS letters. 2023. 597. 19. 2433-2445
Yuto Sasaki, Kodai Saitoh, Kota Kagohashi, Toyoyuki Ose, Shoya Kawahara, Yuichi Kitai, Ryuta Muromoto, Yuichi Sekine, Michiko Ichii, Akihiko Yoshimura, et al. STAP-2-Derived Peptide Suppresses TCR-Mediated Signals to Initiate Immune Responses. The Journal of Immunology. 2023
Taiga Maemoto, Yuichi Kitai, Runa Takahashi, Haruka Shoji, Shunsuke Yamada, Shiho Takei, Daiki Ito, Ryuta Muromoto, Jun-Ichi Kashiwakura, Haruka Handa, et al. A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling. The Journal of biological chemistry. 2022. 299. 1. 102724-102724
Shigeru Hashimoto, Ari Hashimoto, Ryuta Muromoto, Yuichi Kitai, Kenji Oritani, Tadashi Matsuda. Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance. Cells. 2022. 11. 16

ｍore...

MISC (97)：

室本竜太. Study on immunotoxicity through mRNA stability control mechanism. ImmunoTox Letter (Web). 2023. 55
松田正, 室本竜太, 鍛代悠一, 織谷健司. 【IL-6阻害療法の基礎と臨床】IL-6とそのシグナル伝達系の分子基盤. リウマチ科. 2023. 69. 1. 1-12
成家康太, 室本竜太, 松田正. Benzo[a]pyrene enhances IL-17-mediated responses by suppressing expression of Regnase-1 through AhR. 日本薬学会年会要旨集(Web). 2022. 142nd
室本竜太. Study on immunotoxicity through mRNA stability control mechanism. 日本免疫毒性学会学術年会講演要旨集. 2022. 29th
田中伸英, 村上侑斗, 平島洸基, 福田隼, 藤原広一, 渡邉瑞貴, 室本竜太, 松田正, 周東智. 抗炎症脂質レゾルビンE2の1,4,7-トリエン-ベンゼン置換による安定等価体の創製研究. 反応と合成の進歩シンポジウム講演要旨集. 2022. 48th

ｍore...

Patents (1)：

Education (2)：

2002 - 2007 Hokkaido University Graduate School, Division of Pharmaceutical Sciences
1998 - 2002 Hokkaido University Faculty of Pharmaceutical Sciences

Professional career (1)：

Work history (4)：

2022/03 - 現在 Hokkaido University Faculty of Pharmaceutical Sciences Associate professor
2016/04 - 2022/02 Hokkaido University Faculty of Pharmaceutical Sciences Lecturer
2007/04 - 2016/03 Hokkaido University Faculty of Pharmaceutical Sciences Assistant Professor
2006/04 - 2007/03 日本学術振興会特別研究員

Committee career (3)：

Awards (4)：

Association Membership(s) (3)：

The Japanese Society of Immunotoxicology , 日本薬学会 , 日本免疫学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page